1. Home
  2. LCLN vs ACHV Comparison

LCLN vs ACHV Comparison

Compare LCLN & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln International Inc. Class A Common Stock

LCLN

Lincoln International Inc. Class A Common Stock

N/A

Current Price

$23.41

Market Cap

821.7M

Sector

Finance

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.55

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCLN
ACHV
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.7M
726.5M
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
LCLN
ACHV
Price
$23.41
$7.55
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
★ $27.64
$13.83
AVG Volume (30 Days)
530.2K
★ 1.4M
Earning Date
11-15-2026
11-05-2026
Dividend Yield
★ 1.21%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$29.85
N/A
Revenue Next Year
$14.26
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.05
$2.62
52 Week High
$27.55
$8.64

Technical Indicators

Market Signals
Indicator
LCLN
ACHV
Relative Strength Index (RSI) 39.19 53.53
Support Level $23.01 $7.01
Resistance Level $23.75 $8.56
Average True Range (ATR) 1.02 0.36
MACD -0.35 -0.01
Stochastic Oscillator 9.48 62.91

Price Performance

Historical Comparison
LCLN
ACHV

About LCLN Lincoln International Inc. Class A Common Stock

Lincoln International Inc is an independent investment banking advisory company focused on private capital markets. The company operates its business through its two operating segments: Investment Banking Advisory and Valuations and Opinions. The Investment Banking Advisory segment offers a range of services related to mergers and acquisitions, with key areas of focus including sell-side advisory, buy-side advisory, asset sales and divestitures, restructuring, primary and secondary capital raising, and merger-related engagements. The Valuations and Opinions segment provides valuation services to investment funds and financial institutions. The majority of revenue is derived from the Investment Banking Advisory segment. Geographically, the maximum revenue is derived from the Americas.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: